Navigation Links
Aethlon Medical to Present at Source Capital Group's 2016 Disruptive Growth & Healthcare Conference on February 10, 2016
Date:2/5/2016

SAN DIEGO, Feb. 5, 2016 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), today announced that Jim Joyce, Chairman and CEO, will be presenting at Source Capital Group's 2016 Disruptive Growth & Healthcare Conference in New York, NY at 2:15 p.m. ET on Wednesday, February 10, 2016.  Mr. Joyce will also participate in an Immunotherapy Panel discussion taking place at 3:15 p.m. ET.

The presentation will be made available to the public via live audio webcast which can be accessed by visiting the investor relations section of Aethlon Medical's corporate website at http://www.aethlonmedical.com.  The webcast will be available for replay approximately one hour after the conclusion of the live event. The panel discussion will not be webcast.

Aethlon Medical will also be presenting at the BIO CEO & Investor Conference in New York, NY at 3:30 p.m. ET on Tuesday, February 9, 2016.  A webcast of the presentation can be accessed by visiting the investor relations section of Aethlon Medical's corporate website at http://www.aethlonmedical.com.

About Aethlon Medical, Inc.

Aethlon Medical creates affinity biofiltration devices to treat life-threatening diseases.  The Aethlon Hemopurifier® is a leading broad-spectrum treatment countermeasure against infectious viral pathogens.  The device, which has been successfully administered to individuals infected with HIV, Hepatitis C (HCV) and Ebola virus, is currently the subject of FDA approved clinical studies.  Aethlon is also studying the potential use of the Hemopurifier® to address exosomes secreted by tumors to promote the spread of metastasis and suppress the immune system of cancer patients.  The Company provides government contracting services to the Defense Advanced Research Projects Agency (DARPA) related to the development of a biofiltration device to treat sepsis and maintains majority ownership of Exosome Sciences, Inc., which is focused on the discovery of exosomal biomarkers to diagnose and monitor Chronic Traumatic Encephalopathy (CTE) and other neurological disorders.  Additional information can be found online at www.AethlonMedical.com or you can connect with us on Twitter, LinkedIn, Facebook and Google+.

Contacts:

Mike Smargiassi/Brad Edwards
Brainerd Communicators, Inc
212-986-6667
smarg@braincomm.com

Photo - http://photos.prnewswire.com/prnh/20090325/LA88762LOGO-b

 


'/>"/>
SOURCE Aethlon Medical, Inc.
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Aethlon Medical Announces the Appointment of Chetan S. Shah, M.D. to its Board of Directors
2. Aethlon Medical to Present at Exosomes and Circulating Biomarkers 2013 Summit
3. Aethlon Medical Announces Launch of Exosome Sciences Subsidiary
4. Aethlon Medical Announces Dr. Douglas Taylor as Chief Scientific Officer of Exosome Sciences, Inc.
5. Aethlon Medical Announces the Appointment of Dr. Cicek Gercel-Taylor as Clinical Research Director of Exosome Sciences, Inc.
6. Aethlon Medical (AEMD) Note: Cancer Immunotherapy Article, Introduction to Dr. Douglas Taylor
7. Aethlon Medical to Present at SeeThruEquity Investor Conference
8. Aethlon Medical to Present at Biotech Showcase Investor Conference
9. Aethlon Medical and Exosome Sciences Announce the Advancement of a Broad-Spectrum Cancer Detection and Monitoring Platform
10. Aethlon Medical Receives Notice of DARPA Contract Renewal
11. Aethlon Medical Announces Dengue Virus Treatment Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/11/2019)... Va. (PRWEB) , ... September 11, 2019 , ... ... revolutionizing image analysis, with many companies developing technologies to evaluate medical images. In ... Unless one understands the approaches the FDA is taking to AI-based image analysis, ...
(Date:9/11/2019)... ... September 11, 2019 , ... Bloodstream ... in the US. However, patients may not receive the most targeted therapy in ... Rapid molecular detection of these pathogens has shown improvement in patient outcomes, but ...
(Date:9/11/2019)... ... September 11, 2019 , ... ... elder care innovator HomeThrive has selected LifePod’s voice-first service for rollout to an ... to adults over the age of 50, demand has steadily increased for solutions ...
Breaking Medicine Technology:
(Date:9/11/2019)... ... September 12, 2019 , ... “Heart Seizures”: a useful source ... artery disease as he hopes to prevent anyone from having it and to help ... John Saltwick, a writer who was diagnosed with coronary artery disease. Predicted to experience ...
(Date:9/11/2019)... ... September 11, 2019 , ... GRM Information Management, a ... Data and Information Conference in Chicago, Illinois September 14 to 18. , ... about GRM’s healthcare information management solutions . , Built around their robust, ...
(Date:9/11/2019)... ... ... Executives at health systems and hospitals across America are facing some formidable ... several years has been intense. For professionals and organizations that struggle with change, it’s ... largely on how these executives respond. Will they have the tools they need to ...
(Date:9/11/2019)... ... September 10, 2019 , ... Episcopal Relief & Development is ... impacted by Hurricane Dorian. , In partnership with the Episcopal Diocese of ... and the Episcopal Farmworker Ministry, Episcopal Relief & Development is giving assistance such ...
(Date:9/9/2019)... ... September 09, 2019 , ... Cardinal Park Family Dental Care is ... counting. The practice offers family dentistry , laser gum disease treatment, full mouth ... the 20th year that Cardinal Park Family Dental Care has provided state-of-the-art, comprehensive dental ...
Breaking Medicine News(10 mins):